The Patent Finder

Peptide Fragments for Inducing Synthesis of Extracellular Matrix Proteins

Helix, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application 60/813,284, filed Jun 13, 2006. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 8,962,798Peptide Fragments for Inducing Synthesis of Extracellular Matrix Proteins
In force
 · High confidence
Helix Biomedix, Inc.In force
High confidence
US 10,376,557Peptide Fragments for Inducing Synthesis of Extracellular Matrix Proteins
In force
 · High confidence
Helix Biomedix Inc.In force
High confidence
US 8,658,764Peptide Fragments for Inducing Synthesis of Extracellular Matrix Proteins
In force
 · High confidence
Helix Biomedix, Inc.In force
High confidence
US 8,110,658Peptide Fragments for Inducing Synthesis of Extracellular Matrix Proteins
In force
 · High confidence
Helix Biomedix, Inc.In force
High confidence
US 9,447,143Peptide Fragments for Inducing Synthesis of Extracellular Matrix Proteins
Lapsed Sep 20, 2020 on the fee record
Ended Sep 20, 2020 · High confidence
Helix Biomedix Inc.Lapsed Sep 20, 2020 on the fee recordEnded Sep 20, 2020
High confidence
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Helix, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited